COPD market to reach $30.8 billion in 7 major markets by 2033, forecasts GlobalData

The COPD market in the seven major markets (7MM) is expected to grow significantly by 2033, reaching $30.8 billion, driven by the launch of the first biologic for COPD and other innovative pipeline agents. This growth will be supported by the approval of Sanofi and Regeneron’s Dupixent, the first biologic for COPD, by the FDA […]